Investors / United States / Phase Two Ventures
Phase Two Ventures
Venture capital · San Diego, CA, United States · North America
Phase Two Ventures is a seed venture fund based in San Diego that invests in early-stage life science tools, platform technologies, and AI x Bio. It provides capital, coaching, and support to pre-seed and seed founders, drawing on partners' operating experience founding and scaling life science companies.
Invests inHealthcare & Biotech
In its own wordslife science toolsplatform technologiesai x biomulti-omicssynthetic biologycell and gene therapy
Your fit with Phase Two Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsPhase Two Ventures lists 14 checked portfolio companies on its own site. Its largest theme is Healthcare & Biotech (100%). 89% of its companies are based in United States. It invests most often alongside Creative Destruction Lab, Illumina Ventures and IndieBio.
No funding round on record names Phase Two Ventures yet, so the figures come from its portfolio page.
Round figures show recent activity, not Phase Two Ventures' whole history. Rounds on record name 0 companies; its own site lists 14. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 33th | 13 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 42th | 2 countries |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers14100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Creative Destruction Lab
Compare Phase Two Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
14 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Acurion develops and provides a technology called OncoGaze that delivers genomic insights to help oncologists make precision therapy decisions for cancer patients | Healthcare & Biotech | Portfolio page | ||
| The company simplifies mass spec sample preparation | Healthcare & Biotech | Portfolio page | ||
| Arima Genomics is building DNA-based cancer diagnostics that bring sequence and structure together to find more of what drives disease | Healthcare & Biotech | Portfolio page | ||
| Augment Biologics is the first and only AI-powered glycoprotein design company. | Healthcare & Biotech | Portfolio page | ||
| Defined Bioscience develops and sells serum-free stem cell media and supporting reagents for cell culture. | Healthcare & Biotech | Portfolio page | ||
| The company develops technologies to manage patient variability and make local production of cell therapies possible | Healthcare & Biotech | Portfolio page | ||
| GelTech Labs provides automated lab services for research and development of soft biomaterials. | Healthcare & Biotech | Portfolio page | ||
| Lynx Bio is a biotech company that develops immunotherapies using a multi-omic platform | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| NanoCellect Biomedical develops and sells microfluidic cell sorters for gentle sorting of cells. | Healthcare & Biotech | Portfolio page | ||
| Navega Therapeutics develops gene therapies for chronic pain and precision pain management. | Healthcare & Biotech | Portfolio page | ||
| Novoron Bioscience develops innovative therapies to restore independence and improve patient's lives by pioneering lipoprotein-receptor drug development to repair damage and degeneration of the brain, spinal cord and beyond. | Healthcare & Biotech | Portfolio page | ||
| Potato builds AI-native software that helps scientists research methods, build protocols, design experiments, and improve plate-based assays in one connected workspace. | Healthcare & Biotech | Portfolio page | ||
| Rybodyn develops immunotherapies by unlocking the dark proteome with its proprietary technology. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- phasetwo.vc
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Companies checked
- 14
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Phase Two Ventures' profile as data
Pull Phase Two Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/phasetwo.vc
# also
GET /v1/firms/phasetwo.vc/portfolio
GET /v1/firms/phasetwo.vc/coinvestors
GET /v1/firms/phasetwo.vc/news